| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | olfactory receptor activity | OR8J3 OR5AK2 OR7A5 OR4Q2 OR13C3 OR4M1 OR4Q3 OR5AK3P OR8J1 OR5M8 OR11H12 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 OR5AC2 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 OR4K5 OR8B2 OR4X1 OR4K15 OR2AG1 | 2.69e-25 | 431 | 107 | 30 | GO:0004984 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR8J3 OR5AK2 OR7A5 OR4Q2 AVPR1A OR13C3 OR4M1 OR4Q3 OR5AK3P OR8J1 OR5M8 OR11H12 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 OR5AC2 P2RY1 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 TACR2 OR4K5 TACR1 TACR3 OR8B2 OR4X1 OR4K15 OR2AG1 | 1.97e-21 | 884 | 107 | 35 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR8J3 OR5AK2 OR7A5 OR4Q2 AVPR1A OR13C3 OR4M1 OR4Q3 OR5AK3P GRIK1 OR8J1 OR5M8 OR11H12 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 OR5AC2 P2RY1 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 TACR2 OR4K5 TACR1 TACR3 OR8B2 OR4X1 OR4K15 PLXNA2 OR2AG1 | 2.49e-17 | 1353 | 107 | 37 | GO:0004888 |
| GeneOntologyMolecularFunction | odorant binding | OR8J3 OR5AK2 OR5AK3P OR8J1 OR5M8 OR8B3 OR8A1 OR5AC2 OR5C1 OR8B2 | 1.58e-09 | 127 | 107 | 10 | GO:0005549 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC24A5 TRPM6 SLC46A2 MFSD9 SLC28A3 GRIK1 SLC2A2 SLC7A9 SLC7A8 SLC25A36 SLC8A1 PIEZO2 CLCNKA SLC26A7 KCND2 SLC5A6 SCN4A SCN5A KCNMA1 KCNN3 ATP6V0D2 SLC51A SLC38A3 | 5.40e-08 | 1180 | 107 | 23 | GO:0022857 |
| GeneOntologyMolecularFunction | tachykinin receptor activity | 1.50e-07 | 3 | 107 | 3 | GO:0004995 | |
| GeneOntologyMolecularFunction | transporter activity | SLC24A5 TRPM6 SLC46A2 MFSD9 SLC28A3 GRIK1 SLC2A2 SLC7A9 SLC7A8 SLC25A36 SLC8A1 PIEZO2 CLCNKA SLC26A7 KCND2 SLC5A6 SCN4A SCN5A KCNMA1 KCNN3 ATP6V0D2 SLC51A SLC38A3 | 2.64e-07 | 1289 | 107 | 23 | GO:0005215 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.89e-06 | 171 | 107 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC24A5 TRPM6 SLC28A3 GRIK1 SLC8A1 PIEZO2 CLCNKA SLC26A7 KCND2 SLC5A6 SCN4A SCN5A KCNMA1 KCNN3 ATP6V0D2 SLC38A3 | 4.87e-06 | 793 | 107 | 16 | GO:0015075 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC24A5 TRPM6 SLC28A3 GRIK1 SLC8A1 KCND2 SLC5A6 SCN4A SCN5A KCNMA1 KCNN3 SLC38A3 | 7.40e-06 | 465 | 107 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC24A5 TRPM6 SLC28A3 GRIK1 SLC8A1 PIEZO2 KCND2 SLC5A6 SCN4A SCN5A KCNMA1 KCNN3 ATP6V0D2 SLC38A3 | 1.24e-05 | 664 | 107 | 14 | GO:0008324 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC24A5 TRPM6 SLC28A3 GRIK1 SLC8A1 CLCNKA SLC26A7 KCND2 SLC5A6 SCN4A SCN5A KCNMA1 KCNN3 ATP6V0D2 SLC38A3 | 1.25e-05 | 758 | 107 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC46A2 GRIK1 SLC2A2 SLC7A9 SLC7A8 SLC26A7 SLC5A6 SLC51A SLC38A3 | 2.85e-05 | 293 | 107 | 9 | GO:0008514 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC24A5 SLC46A2 SLC28A3 SLC7A9 SLC7A8 SLC8A1 SLC26A7 SLC5A6 SLC38A3 | 3.08e-05 | 296 | 107 | 9 | GO:0015291 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC24A5 TRPM6 SLC28A3 GRIK1 SLC8A1 KCND2 SLC5A6 SCN4A SCN5A KCNMA1 KCNN3 ATP6V0D2 SLC38A3 | 3.08e-05 | 627 | 107 | 13 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | SLC24A5 TRPM6 GRIK1 PIEZO2 CLCNKA SLC26A7 KCND2 SCN4A SCN5A KCNMA1 KCNN3 | 3.58e-05 | 459 | 107 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 9.59e-05 | 343 | 107 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | antiporter activity | 9.96e-05 | 138 | 107 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | channel activity | SLC24A5 TRPM6 GRIK1 PIEZO2 CLCNKA SLC26A7 KCND2 SCN4A SCN5A KCNMA1 KCNN3 | 1.19e-04 | 525 | 107 | 11 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SLC24A5 TRPM6 GRIK1 PIEZO2 CLCNKA SLC26A7 KCND2 SCN4A SCN5A KCNMA1 KCNN3 | 1.21e-04 | 526 | 107 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.26e-04 | 207 | 107 | 7 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.30e-04 | 208 | 107 | 7 | GO:0005342 | |
| GeneOntologyMolecularFunction | testosterone 16-alpha-hydroxylase activity | 1.69e-04 | 4 | 107 | 2 | GO:0008390 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC24A5 SLC46A2 SLC28A3 SLC7A9 SLC7A8 SLC8A1 SLC26A7 SLC5A6 ATP6V0D2 SLC38A3 | 2.45e-04 | 477 | 107 | 10 | GO:0022804 |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 2.81e-04 | 5 | 107 | 2 | GO:0050649 | |
| GeneOntologyMolecularFunction | vitamin D 23-hydroxylase activity | 2.81e-04 | 5 | 107 | 2 | GO:0062179 | |
| GeneOntologyMolecularFunction | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity | 2.81e-04 | 5 | 107 | 2 | GO:0062181 | |
| GeneOntologyMolecularFunction | vitamin D3 25-hydroxylase activity | 4.21e-04 | 6 | 107 | 2 | GO:0030343 | |
| GeneOntologyMolecularFunction | vitamin D 24-hydroxylase activity | 4.21e-04 | 6 | 107 | 2 | GO:0070576 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 5.75e-04 | 71 | 107 | 4 | GO:0015179 | |
| GeneOntologyMolecularFunction | vitamin D 25-hydroxylase activity | 5.87e-04 | 7 | 107 | 2 | GO:0070643 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 7.80e-04 | 8 | 107 | 2 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 7.80e-04 | 8 | 107 | 2 | GO:0034875 | |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 7.80e-04 | 8 | 107 | 2 | GO:0101021 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 8.64e-04 | 35 | 107 | 3 | GO:0015020 | |
| GeneOntologyMolecularFunction | L-alanine transmembrane transporter activity | 9.99e-04 | 9 | 107 | 2 | GO:0015180 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.19e-03 | 301 | 107 | 7 | GO:0022853 | |
| GeneOntologyMolecularFunction | calcium:sodium antiporter activity | 1.24e-03 | 10 | 107 | 2 | GO:0005432 | |
| GeneOntologyMolecularFunction | symporter activity | 1.29e-03 | 150 | 107 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 1.38e-03 | 41 | 107 | 3 | GO:0015175 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 1.52e-03 | 11 | 107 | 2 | GO:0101020 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 1.58e-03 | 43 | 107 | 3 | GO:0140828 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 2.06e-03 | 167 | 107 | 5 | GO:0015079 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity | 2.13e-03 | 13 | 107 | 2 | GO:0015368 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 2.46e-03 | 105 | 107 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | calcium-activated potassium channel activity | 2.48e-03 | 14 | 107 | 2 | GO:0015269 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 2.48e-03 | 14 | 107 | 2 | GO:0008401 | |
| GeneOntologyMolecularFunction | phosphotyrosine residue binding | 2.58e-03 | 51 | 107 | 3 | GO:0001784 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.73e-03 | 52 | 107 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 2.85e-03 | 15 | 107 | 2 | GO:0016725 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 2.88e-03 | 53 | 107 | 3 | GO:0008188 | |
| GeneOntologyMolecularFunction | alanine transmembrane transporter activity | 3.25e-03 | 16 | 107 | 2 | GO:0022858 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 3.91e-03 | 59 | 107 | 3 | GO:0015932 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.12e-03 | 18 | 107 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 4.30e-03 | 61 | 107 | 3 | GO:1901682 | |
| GeneOntologyMolecularFunction | potassium channel activity | 5.00e-03 | 128 | 107 | 4 | GO:0005267 | |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 5.07e-03 | 20 | 107 | 2 | GO:0015174 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 5.59e-03 | 211 | 107 | 5 | GO:0016758 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 5.72e-03 | 133 | 107 | 4 | GO:0008528 | |
| GeneOntologyMolecularFunction | protein phosphorylated amino acid binding | 6.07e-03 | 69 | 107 | 3 | GO:0045309 | |
| GeneOntologyMolecularFunction | ankyrin binding | 6.69e-03 | 23 | 107 | 2 | GO:0030506 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 6.84e-03 | 140 | 107 | 4 | GO:0001653 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 7.27e-03 | 24 | 107 | 2 | GO:0099507 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 8.50e-03 | 26 | 107 | 2 | GO:0005248 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR8J3 OR5AK2 OR7A5 OR4Q2 OR13C3 OR4M1 OR4Q3 OR5AK3P OR8J1 OR5M8 OR11H12 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 OR5AC2 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 OR4K5 OR8B2 OR4X1 OR4K15 OR2AG1 | 6.13e-26 | 432 | 105 | 30 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR8J3 OR5AK2 OR7A5 OR4Q2 OR13C3 OR4M1 OR4Q3 OR5AK3P OR8J1 OR5M8 OR11H12 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 OR5AC2 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 OR4K5 OR8B2 OR4X1 OR4K15 OR2AG1 | 5.34e-25 | 465 | 105 | 30 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR8J3 OR5AK2 OR7A5 OR4Q2 OR13C3 OR4M1 OR4Q3 OR5AK3P OR8J1 OR5M8 OR11H12 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 OR5AC2 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 OR4K5 OR8B2 OR4X1 OR4K15 OR2AG1 | 1.83e-24 | 485 | 105 | 30 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR8J3 OR5AK2 OR7A5 OR4Q2 OR13C3 OR4M1 OR4Q3 OR5AK3P OR8J1 OR5M8 OR11H12 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 OR5AC2 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 OR4K5 OR8B2 OR4X1 OR4K15 OR2AG1 | 1.74e-23 | 524 | 105 | 30 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR8J3 OR5AK2 OR7A5 OR4Q2 OR13C3 OR4M1 OR4Q3 OR5AK3P OR8J1 OR5M8 OR11H12 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 PIEZO2 OR5AC2 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 OR4K5 OR8B2 OR4X1 OR4K15 OR2AG1 | 2.38e-23 | 582 | 105 | 31 | GO:0050906 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR8J3 OR5AK2 OR7A5 OR4Q2 OR13C3 OR4M1 OR4Q3 OR5AK3P OR8J1 OR5M8 OR11H12 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 OR5AC2 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 OR4K5 OR8B2 OR4X1 OR4K15 OR2AG1 | 6.01e-23 | 547 | 105 | 30 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR8J3 OR5AK2 OR7A5 OR4Q2 OR13C3 OR4M1 OR4Q3 OR5AK3P OR8J1 OR5M8 OR11H12 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 PIEZO2 OR5AC2 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 OR4K5 TACR1 OR8B2 OR4X1 OR4K15 OR2AG1 | 1.08e-21 | 722 | 105 | 32 | GO:0051606 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR8J3 ABL1 ABL2 OR5AK2 OR7A5 OR4Q2 AVPR1A OR13C3 OR4M1 OR4Q3 OR5AK3P OR8J1 OR5M8 OR11H12 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 OR5AC2 P2RY1 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 TACR2 OR4K5 TACR1 TACR3 OR8B2 OR4X1 OR4K15 OR2AG1 | 1.15e-17 | 1395 | 105 | 37 | GO:0007186 |
| GeneOntologyBiologicalProcess | sensory perception | OR8J3 OR5AK2 OR7A5 OR4Q2 OR13C3 OR4M1 OR4Q3 OR5AK3P OR8J1 OR5M8 OR11H12 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 PIEZO2 OR5AC2 OR11H1 KCND2 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 KCNMA1 OR56A3 OR4K5 OR8B2 OR4X1 OR4K15 OR2AG1 | 1.43e-17 | 1072 | 105 | 33 | GO:0007600 |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 1.19e-06 | 37 | 105 | 5 | GO:0042178 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 1.36e-06 | 38 | 105 | 5 | GO:0008209 | |
| GeneOntologyBiologicalProcess | positive regulation of cilium-dependent cell motility | 1.84e-06 | 18 | 105 | 4 | GO:2000155 | |
| GeneOntologyBiologicalProcess | positive regulation of flagellated sperm motility | 1.84e-06 | 18 | 105 | 4 | GO:1902093 | |
| GeneOntologyBiologicalProcess | positive regulation of cilium movement | 2.32e-06 | 19 | 105 | 4 | GO:0003353 | |
| GeneOntologyBiologicalProcess | circulatory system process | ABL1 AVPR1A PPARA SLC7A8 SLC8A1 P2RY1 KCND2 SLC5A6 SCN4A SCN5A KCNMA1 TACR2 TACR1 TACR3 SLC38A3 | 4.51e-06 | 733 | 105 | 15 | GO:0003013 |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 6.67e-06 | 52 | 105 | 5 | GO:0008210 | |
| GeneOntologyBiologicalProcess | tachykinin receptor signaling pathway | 7.05e-06 | 8 | 105 | 3 | GO:0007217 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 7.05e-06 | 8 | 105 | 3 | GO:0070980 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | ABL1 AVPR1A SLC7A8 SLC8A1 P2RY1 SLC5A6 KCNMA1 TACR2 TACR1 SLC38A3 | 1.04e-05 | 344 | 105 | 10 | GO:0003018 |
| GeneOntologyBiologicalProcess | positive regulation of uterine smooth muscle contraction | 1.05e-05 | 9 | 105 | 3 | GO:0070474 | |
| GeneOntologyBiologicalProcess | regulation of flagellated sperm motility | 1.18e-05 | 28 | 105 | 4 | GO:1901317 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 1.21e-05 | 210 | 105 | 8 | GO:0060294 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 1.43e-05 | 215 | 105 | 8 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 1.43e-05 | 215 | 105 | 8 | GO:0001539 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 1.50e-05 | 10 | 105 | 3 | GO:0018879 | |
| GeneOntologyBiologicalProcess | response to carbon monoxide | 2.57e-05 | 2 | 105 | 2 | GO:0034465 | |
| GeneOntologyBiologicalProcess | regulation of uterine smooth muscle contraction | 2.73e-05 | 12 | 105 | 3 | GO:0070472 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 2.73e-05 | 12 | 105 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | uterine smooth muscle contraction | 3.53e-05 | 13 | 105 | 3 | GO:0070471 | |
| GeneOntologyBiologicalProcess | aggressive behavior | 3.53e-05 | 13 | 105 | 3 | GO:0002118 | |
| GeneOntologyBiologicalProcess | regulation of cilium movement involved in cell motility | 3.68e-05 | 37 | 105 | 4 | GO:0060295 | |
| GeneOntologyBiologicalProcess | regulation of cilium-dependent cell motility | 3.68e-05 | 37 | 105 | 4 | GO:1902019 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | SRD5A3 CYP3A4 CYP3A43 SLC2A2 SLC7A8 P2RY1 SLC26A7 KCNMA1 UGT2B7 TACR2 TACR1 UGT2B28 UGT2B11 | 4.43e-05 | 684 | 105 | 13 | GO:0010817 |
| GeneOntologyBiologicalProcess | flagellated sperm motility | 4.68e-05 | 186 | 105 | 7 | GO:0030317 | |
| GeneOntologyBiologicalProcess | cilium movement | 5.71e-05 | 261 | 105 | 8 | GO:0003341 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC24A5 TRPM6 ABL1 SLC28A3 GRIK1 SLC8A1 PIEZO2 CLCNKA P2RY1 SLC26A7 KCND2 SLC5A6 SCN4A SCN5A KCNMA1 KCNN3 TACR2 ATP6V0D2 SLC38A3 | 5.87e-05 | 1374 | 105 | 19 | GO:0006811 |
| GeneOntologyBiologicalProcess | sperm motility | 5.92e-05 | 193 | 105 | 7 | GO:0097722 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC46A2 AVPR1A GRIK1 PPARA SLC2A2 SLC7A9 SLC7A8 SLC26A7 SLC5A6 SLC51A SLC38A3 | 6.35e-05 | 515 | 105 | 11 | GO:0015711 |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 7.88e-05 | 202 | 105 | 7 | GO:0006937 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 8.23e-05 | 275 | 105 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 8.47e-05 | 141 | 105 | 6 | GO:0006805 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 9.46e-05 | 208 | 105 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 1.08e-04 | 286 | 105 | 8 | GO:0042445 | |
| GeneOntologyBiologicalProcess | regulation of cilium movement | 1.13e-04 | 49 | 105 | 4 | GO:0003352 | |
| GeneOntologyBiologicalProcess | blood circulation | ABL1 AVPR1A PPARA SLC8A1 P2RY1 KCND2 SCN4A SCN5A KCNMA1 TACR2 TACR1 TACR3 | 1.13e-04 | 648 | 105 | 12 | GO:0008015 |
| GeneOntologyBiologicalProcess | DN4 thymocyte differentiation | 1.53e-04 | 4 | 105 | 2 | GO:1904157 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of T cell polarity | 1.53e-04 | 4 | 105 | 2 | GO:1903905 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC24A5 TRPM6 ABL1 SLC28A3 GRIK1 SLC8A1 PIEZO2 CLCNKA SLC26A7 KCND2 SLC5A6 SCN4A SCN5A KCNMA1 KCNN3 ATP6V0D2 | 1.59e-04 | 1115 | 105 | 16 | GO:0034220 |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.59e-04 | 21 | 105 | 3 | GO:0052695 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC24A5 TRPM6 ABL1 SLC28A3 GRIK1 SLC8A1 CLCNKA SLC26A7 KCND2 SLC5A6 SCN4A SCN5A KCNMA1 KCNN3 ATP6V0D2 | 1.94e-04 | 1017 | 105 | 15 | GO:0098660 |
| GeneOntologyBiologicalProcess | positive regulation of amine transport | 2.18e-04 | 58 | 105 | 4 | GO:0051954 | |
| GeneOntologyBiologicalProcess | regulation of muscle system process | 2.18e-04 | 317 | 105 | 8 | GO:0090257 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | AVPR1A GRIK1 PPARA SLC7A9 SLC7A8 SLC26A7 SLC5A6 SLC51A SLC38A3 | 2.48e-04 | 410 | 105 | 9 | GO:0046942 |
| GeneOntologyBiologicalProcess | operant conditioning | 2.54e-04 | 5 | 105 | 2 | GO:0035106 | |
| GeneOntologyBiologicalProcess | alkaloid catabolic process | 2.54e-04 | 5 | 105 | 2 | GO:0009822 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction involved in micturition | 2.54e-04 | 5 | 105 | 2 | GO:0060083 | |
| GeneOntologyBiologicalProcess | organic acid transport | AVPR1A GRIK1 PPARA SLC7A9 SLC7A8 SLC26A7 SLC5A6 SLC51A SLC38A3 | 2.57e-04 | 412 | 105 | 9 | GO:0015849 |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.71e-04 | 112 | 105 | 5 | GO:0019226 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC24A5 TRPM6 ABL1 SLC28A3 GRIK1 SLC8A1 PIEZO2 KCND2 SLC5A6 SCN4A SCN5A KCNMA1 KCNN3 ATP6V0D2 | 2.99e-04 | 942 | 105 | 14 | GO:0098655 |
| GeneOntologyBiologicalProcess | neuronal action potential | 3.00e-04 | 63 | 105 | 4 | GO:0019228 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 3.06e-04 | 26 | 105 | 3 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 3.06e-04 | 26 | 105 | 3 | GO:0006063 | |
| GeneOntologyBiologicalProcess | sodium ion import across plasma membrane | 3.43e-04 | 27 | 105 | 3 | GO:0098719 | |
| GeneOntologyBiologicalProcess | copulation | 3.43e-04 | 27 | 105 | 3 | GO:0007620 | |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 3.45e-04 | 118 | 105 | 5 | GO:2000243 | |
| GeneOntologyBiologicalProcess | regulation of system process | ABL1 AVPR1A GRIK1 PPARA SLC8A1 KCND2 SCN4A SCN5A KCNMA1 TACR2 TACR1 TACR3 | 3.56e-04 | 734 | 105 | 12 | GO:0044057 |
| GeneOntologyBiologicalProcess | regulation of establishment of T cell polarity | 3.80e-04 | 6 | 105 | 2 | GO:1903903 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 3.87e-04 | 121 | 105 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based movement | 4.02e-04 | 68 | 105 | 4 | GO:0060632 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 4.49e-04 | 125 | 105 | 5 | GO:0051952 | |
| GeneOntologyBiologicalProcess | muscle system process | PPARA SLC8A1 P2RY1 KCND2 SCN4A SCN5A KCNMA1 TACR2 TACR1 TACR3 | 4.79e-04 | 547 | 105 | 10 | GO:0003012 |
| GeneOntologyBiologicalProcess | sperm ejaculation | 5.30e-04 | 7 | 105 | 2 | GO:0042713 | |
| GeneOntologyBiologicalProcess | establishment of mitotic sister chromatid cohesion | 5.30e-04 | 7 | 105 | 2 | GO:0034087 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | ABL1 GRIK1 SLC25A36 SLC8A1 PIEZO2 KCND2 SCN4A SCN5A KCNMA1 TACR1 | 5.67e-04 | 559 | 105 | 10 | GO:0042391 |
| GeneOntologyBiologicalProcess | action potential | 5.75e-04 | 201 | 105 | 6 | GO:0001508 | |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 5.90e-04 | 202 | 105 | 6 | GO:0035296 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 5.90e-04 | 202 | 105 | 6 | GO:0097746 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 5.96e-04 | 133 | 105 | 5 | GO:0006939 | |
| GeneOntologyBiologicalProcess | regulation of tube size | 6.05e-04 | 203 | 105 | 6 | GO:0035150 | |
| GeneOntologyBiologicalProcess | amine transport | 6.82e-04 | 137 | 105 | 5 | GO:0015837 | |
| GeneOntologyBiologicalProcess | positive regulation of amino acid transport | 6.84e-04 | 34 | 105 | 3 | GO:0051957 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle contraction | 7.11e-04 | 79 | 105 | 4 | GO:0006940 | |
| GeneOntologyBiologicalProcess | positive regulation of heart rate | 7.45e-04 | 35 | 105 | 3 | GO:0010460 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC24A5 TRPM6 ABL1 SLC28A3 GRIK1 SLC8A1 PIEZO2 KCND2 SLC5A6 SCN4A SCN5A KCNMA1 KCNN3 ATP6V0D2 SLC38A3 | 7.54e-04 | 1157 | 105 | 15 | GO:0006812 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 8.10e-04 | 36 | 105 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle contraction | 8.10e-04 | 36 | 105 | 3 | GO:0045987 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC24A5 TRPM6 ABL1 SLC28A3 GRIK1 SLC8A1 KCND2 SLC5A6 SCN4A SCN5A KCNMA1 KCNN3 ATP6V0D2 | 8.12e-04 | 922 | 105 | 13 | GO:0098662 |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 8.78e-04 | 37 | 105 | 3 | GO:0042537 | |
| GeneOntologyBiologicalProcess | organic cation transport | 8.80e-04 | 145 | 105 | 5 | GO:0015695 | |
| GeneOntologyBiologicalProcess | alkaloid metabolic process | 9.03e-04 | 9 | 105 | 2 | GO:0009820 | |
| GeneOntologyBiologicalProcess | lipid hydroxylation | 9.03e-04 | 9 | 105 | 2 | GO:0002933 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 9.64e-04 | 222 | 105 | 6 | GO:0071466 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell apoptotic process | 9.77e-04 | 86 | 105 | 4 | GO:1904036 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 1.01e-03 | 224 | 105 | 6 | GO:0007204 | |
| GeneOntologyBiologicalProcess | muscle contraction | 1.01e-03 | 400 | 105 | 8 | GO:0006936 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.02e-03 | 87 | 105 | 4 | GO:0086001 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 1.02e-03 | 87 | 105 | 4 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 1.07e-03 | 88 | 105 | 4 | GO:0010232 | |
| GeneOntologyBiologicalProcess | negative regulation of endothelial cell apoptotic process | 1.10e-03 | 40 | 105 | 3 | GO:2000352 | |
| GeneOntologyBiologicalProcess | positive regulation of Wnt signaling pathway, planar cell polarity pathway | 1.12e-03 | 10 | 105 | 2 | GO:2000096 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | SLC2A2 SLC7A8 SLC8A1 CLCNKA P2RY1 SLC26A7 SLC5A6 SLC51A SLC38A3 | 3.97e-05 | 320 | 107 | 9 | GO:0016323 |
| GeneOntologyCellularComponent | apical plasma membrane | TRPM6 SLC2A2 SLC7A9 SLC7A8 CLCNKA P2RY1 SLC26A7 SLC5A6 KCNMA1 ATP6V0D2 SLC38A3 | 4.06e-05 | 487 | 107 | 11 | GO:0016324 |
| GeneOntologyCellularComponent | brush border membrane | 6.76e-05 | 83 | 107 | 5 | GO:0031526 | |
| GeneOntologyCellularComponent | basal plasma membrane | SLC2A2 SLC7A8 SLC8A1 CLCNKA P2RY1 SLC26A7 SLC5A6 SLC51A SLC38A3 | 8.64e-05 | 354 | 107 | 9 | GO:0009925 |
| GeneOntologyCellularComponent | basal part of cell | SLC2A2 SLC7A8 SLC8A1 CLCNKA P2RY1 SLC26A7 SLC5A6 SLC51A SLC38A3 | 1.42e-04 | 378 | 107 | 9 | GO:0045178 |
| GeneOntologyCellularComponent | 9+2 motile cilium | 2.25e-04 | 238 | 107 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | apical part of cell | TRPM6 SLC2A2 SLC7A9 SLC7A8 CLCNKA P2RY1 SLC26A7 SLC5A6 KCNMA1 ATP6V0D2 SLC38A3 | 2.27e-04 | 592 | 107 | 11 | GO:0045177 |
| GeneOntologyCellularComponent | sodium channel complex | 4.32e-04 | 29 | 107 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | mitotic cohesin complex | 5.36e-04 | 7 | 107 | 2 | GO:0030892 | |
| GeneOntologyCellularComponent | sperm flagellum | 8.22e-04 | 214 | 107 | 6 | GO:0036126 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | SRD5A3 OR7A5 HACD3 CYP3A4 CYP3A43 TMEM39B SLC28A3 ERGIC2 STT3A OR8A1 UGT2B7 UGT2B28 HAS2 SLC51A UGT2B11 TMEM86A | 8.75e-04 | 1293 | 107 | 16 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | SRD5A3 OR7A5 HACD3 CYP3A4 CYP3A43 TMEM39B SLC28A3 ERGIC2 STT3A OR8A1 UGT2B7 UGT2B28 HAS2 SLC51A UGT2B11 TMEM86A | 9.19e-04 | 1299 | 107 | 16 | GO:0098827 |
| GeneOntologyCellularComponent | brush border | 1.12e-03 | 152 | 107 | 5 | GO:0005903 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 1.12e-03 | 40 | 107 | 3 | GO:0005640 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | SRD5A3 OR7A5 HACD3 CYP3A4 CYP3A43 TMEM39B SLC28A3 ERGIC2 STT3A OR8A1 UGT2B7 UGT2B28 HAS2 SLC51A UGT2B11 TMEM86A | 1.15e-03 | 1327 | 107 | 16 | GO:0042175 |
| GeneOntologyCellularComponent | cation channel complex | 1.33e-03 | 235 | 107 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | cohesin complex | 1.39e-03 | 11 | 107 | 2 | GO:0008278 | |
| GeneOntologyCellularComponent | outer dynein arm | 1.66e-03 | 12 | 107 | 2 | GO:0036157 | |
| GeneOntologyCellularComponent | transporter complex | CATSPERD GRIK1 ERGIC2 CLCNKA KCND2 SCN4A SCN5A KCNMA1 ATP6V0D2 | 2.07e-03 | 550 | 107 | 9 | GO:1990351 |
| GeneOntologyCellularComponent | motile cilium | 2.35e-03 | 355 | 107 | 7 | GO:0031514 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 3.32e-03 | 378 | 107 | 7 | GO:0034702 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 3.36e-03 | 17 | 107 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | sperm midpiece | 4.33e-03 | 64 | 107 | 3 | GO:0097225 | |
| MousePheno | decreased circulating hormone level | IL10 AVPR1A OR4M1 KBTBD2 SLC2A2 SLC26A7 SCN4A TACR2 TACR1 TACR3 SLC38A3 | 2.25e-05 | 551 | 61 | 11 | MP:0014457 |
| MousePheno | abnormal pulmonary respiratory rate response | 5.60e-05 | 3 | 61 | 2 | MP:0020844 | |
| MousePheno | decreased hormone level | IL10 AVPR1A OR4M1 KBTBD2 SLC2A2 SLC26A7 SCN4A TACR2 TACR1 TACR3 SLC38A3 | 8.19e-05 | 635 | 61 | 11 | MP:0014455 |
| Domain | Olfact_rcpt | OR8J3 OR5AK2 OR7A5 OR13C3 OR4M1 OR4Q3 OR8J1 OR5M8 OR11H12 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 OR5AC2 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 OR4K5 OR8B2 OR4X1 OR4K15 OR2AG1 | 1.33e-23 | 393 | 103 | 28 | IPR000725 |
| Domain | 7tm_1 | OR8J3 OR5AK2 OR7A5 AVPR1A OR13C3 OR4M1 OR4Q3 OR8J1 OR5M8 OR11H12 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 OR5AC2 P2RY1 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 TACR2 OR4K5 TACR1 TACR3 OR8B2 OR4X1 OR4K15 OR2AG1 | 1.16e-22 | 677 | 103 | 33 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR8J3 OR5AK2 OR7A5 AVPR1A OR13C3 OR4M1 OR4Q3 OR8J1 OR5M8 OR11H12 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 OR5AC2 P2RY1 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 TACR2 OR4K5 TACR1 TACR3 OR8B2 OR4X1 OR4K15 OR2AG1 | 1.68e-22 | 685 | 103 | 33 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR8J3 OR5AK2 OR7A5 AVPR1A OR13C3 OR4M1 OR4Q3 OR8J1 OR5M8 OR11H12 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 OR5AC2 P2RY1 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 TACR2 OR4K5 TACR1 TACR3 OR8B2 OR4X1 OR4K15 OR2AG1 | 2.20e-22 | 691 | 103 | 33 | PS50262 |
| Domain | GPCR_Rhodpsn | OR8J3 OR5AK2 OR7A5 AVPR1A OR13C3 OR4M1 OR4Q3 OR8J1 OR5M8 OR11H12 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 OR5AC2 P2RY1 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 TACR2 OR4K5 TACR1 TACR3 OR8B2 OR4X1 OR4K15 OR2AG1 | 2.30e-22 | 692 | 103 | 33 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | OR8J3 OR5AK2 OR7A5 AVPR1A OR13C3 OR4M1 OR4Q3 OR8J1 OR5M8 OR11H12 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 OR5AC2 P2RY1 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 TACR2 OR4K5 TACR1 TACR3 OR8B2 OR4X1 OR4K15 OR2AG1 | 1.10e-21 | 670 | 103 | 32 | IPR017452 |
| Domain | Neurokn_rcpt | 1.63e-07 | 3 | 103 | 3 | IPR001681 | |
| Domain | FABD | 3.01e-05 | 2 | 103 | 2 | SM00808 | |
| Domain | F_actin_bind | 3.01e-05 | 2 | 103 | 2 | PF08919 | |
| Domain | F-actin_binding | 3.01e-05 | 2 | 103 | 2 | IPR015015 | |
| Domain | STAG | 1.79e-04 | 4 | 103 | 2 | IPR013721 | |
| Domain | SCD | 1.79e-04 | 4 | 103 | 2 | PS51425 | |
| Domain | SCD | 1.79e-04 | 4 | 103 | 2 | IPR020839 | |
| Domain | STAG | 1.79e-04 | 4 | 103 | 2 | PF08514 | |
| Domain | UDPGT | 2.02e-04 | 21 | 103 | 3 | PF00201 | |
| Domain | UDPGT | 2.02e-04 | 21 | 103 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 2.02e-04 | 21 | 103 | 3 | IPR002213 | |
| Domain | Cyt_P450_E_grp-II | 2.98e-04 | 5 | 103 | 2 | IPR002402 | |
| Domain | Tet-R_TetA/multi-R_MdtG | 2.98e-04 | 5 | 103 | 2 | IPR001958 | |
| Domain | PI3kinase_P85 | 2.98e-04 | 5 | 103 | 2 | IPR001720 | |
| Domain | Ion_trans_dom | 4.22e-04 | 114 | 103 | 5 | IPR005821 | |
| Domain | Ion_trans | 4.22e-04 | 114 | 103 | 5 | PF00520 | |
| Domain | Cyt_P450_E_CYP3A | 4.45e-04 | 6 | 103 | 2 | IPR008072 | |
| Domain | DHC_N1 | 8.25e-04 | 8 | 103 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 8.25e-04 | 8 | 103 | 2 | IPR013594 | |
| Domain | NaCa_Exmemb | 1.06e-03 | 9 | 103 | 2 | IPR004837 | |
| Domain | Na_Ca_ex | 1.06e-03 | 9 | 103 | 2 | PF01699 | |
| Domain | Na_channel_asu | 1.32e-03 | 10 | 103 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 1.32e-03 | 10 | 103 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 1.32e-03 | 10 | 103 | 2 | PF06512 | |
| Domain | AA_permease_2 | 2.26e-03 | 13 | 103 | 2 | PF13520 | |
| Domain | AA/rel_permease1 | 2.26e-03 | 13 | 103 | 2 | IPR002293 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.62e-03 | 14 | 103 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.62e-03 | 14 | 103 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.62e-03 | 14 | 103 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.62e-03 | 14 | 103 | 2 | PF08393 | |
| Domain | MT | 2.62e-03 | 14 | 103 | 2 | PF12777 | |
| Domain | AAA_8 | 2.62e-03 | 14 | 103 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 2.62e-03 | 14 | 103 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.62e-03 | 14 | 103 | 2 | PF07728 | |
| Domain | DHC_fam | 3.02e-03 | 15 | 103 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 3.02e-03 | 15 | 103 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 3.02e-03 | 15 | 103 | 2 | PF03028 | |
| Domain | Channel_four-helix_dom | 3.84e-03 | 57 | 103 | 3 | IPR027359 | |
| Domain | - | 3.84e-03 | 57 | 103 | 3 | 1.20.120.350 | |
| Domain | AA-permease/SLC12A_dom | 6.47e-03 | 22 | 103 | 2 | IPR004841 | |
| Domain | AA_permease | 6.47e-03 | 22 | 103 | 2 | PF00324 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR8J3 OR5AK2 OR7A5 OR4Q2 OR13C3 OR4M1 OR4Q3 OR8J1 OR5M8 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 OR5AC2 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 OR4K5 OR8B2 OR4X1 OR4K15 OR2AG1 | 4.41e-22 | 417 | 86 | 28 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR8J3 OR5AK2 OR7A5 OR13C3 OR4M1 OR4Q3 OR8J1 OR5M8 OR1D4 OR4K14 OR52E2 OR51L1 OR8A1 OR5AC2 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 OR4K5 OR4X1 OR4K15 OR2AG1 | 3.22e-19 | 389 | 86 | 25 | M14091 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR8J3 OR5AK2 OR7A5 OR4Q2 OR13C3 OR4M1 OR4Q3 OR8J1 OR5M8 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 OR5AC2 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 KCNMA1 OR56A3 OR4K5 OR8B2 OR4X1 OR4K15 OR2AG1 | 3.03e-18 | 636 | 86 | 29 | M41834 |
| Pathway | REACTOME_PREDNISONE_ADME | 2.32e-07 | 23 | 86 | 5 | MM16639 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 9.86e-07 | 55 | 86 | 6 | M14933 | |
| Pathway | REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS | 2.17e-06 | 5 | 86 | 3 | M27277 | |
| Pathway | REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS | 2.17e-06 | 5 | 86 | 3 | MM14977 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 4.14e-06 | 70 | 86 | 6 | MM14984 | |
| Pathway | REACTOME_ASPIRIN_ADME | 7.58e-06 | 45 | 86 | 5 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 1.42e-05 | 51 | 86 | 5 | M17726 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC24A5 SLC28A3 SLC2A2 SLC7A9 SLC7A8 SLC8A1 SLC26A7 SLC5A6 SLC38A3 | 1.42e-05 | 238 | 86 | 9 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC24A5 SLC28A3 SLC2A2 SLC7A9 SLC7A8 SLC8A1 SLC26A7 SLC5A6 SLC38A3 | 2.04e-05 | 249 | 86 | 9 | M5988 |
| Pathway | KEGG_RETINOL_METABOLISM | 4.32e-05 | 64 | 86 | 5 | M9488 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 5.03e-05 | 108 | 86 | 6 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 5.30e-05 | 109 | 86 | 6 | MM15074 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 6.66e-05 | 70 | 86 | 5 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 7.63e-05 | 72 | 86 | 5 | M9257 | |
| Pathway | REACTOME_DRUG_ADME | 8.65e-05 | 119 | 86 | 6 | MM15692 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.46e-04 | 44 | 86 | 4 | M45014 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 2.40e-04 | 50 | 86 | 4 | M47951 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 2.92e-04 | 210 | 86 | 7 | MM15043 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 3.57e-04 | 217 | 86 | 7 | M18437 | |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 3.99e-04 | 57 | 86 | 4 | M39812 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.04e-04 | 24 | 86 | 3 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.58e-04 | 25 | 86 | 3 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 4.58e-04 | 25 | 86 | 3 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 4.58e-04 | 25 | 86 | 3 | M605 | |
| Pathway | WP_GLUCURONIDATION | 5.15e-04 | 26 | 86 | 3 | M39404 | |
| Pathway | REACTOME_DRUG_ADME | 5.34e-04 | 109 | 86 | 5 | M45012 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 6.43e-04 | 28 | 86 | 3 | M19580 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ESTABLISHMENT_OF_COHESION | 7.57e-04 | 7 | 86 | 2 | M47869 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 7.60e-04 | 178 | 86 | 6 | M2890 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC24A5 TRPM6 SLC28A3 SLC2A2 SLC7A9 SLC7A8 SLC8A1 CLCNKA SLC26A7 SLC5A6 ATP6V0D2 SLC38A3 | 8.41e-04 | 681 | 86 | 12 | MM14985 |
| Pathway | WP_GPCRS_PEPTIDE | 8.71e-04 | 70 | 86 | 4 | MM15959 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 9.57e-04 | 32 | 86 | 3 | MM14957 | |
| Pathway | BIOCARTA_ACETAMINOPHEN_PATHWAY | 1.01e-03 | 8 | 86 | 2 | MM1547 | |
| Pathway | REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING | 1.01e-03 | 8 | 86 | 2 | M27351 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.04e-03 | 260 | 86 | 7 | M39397 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 1.05e-03 | 33 | 86 | 3 | MM1448 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.05e-03 | 33 | 86 | 3 | M188 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 1.07e-03 | 190 | 86 | 6 | MM15687 | |
| Pathway | WP_PEPTIDE_GPCRS | 1.13e-03 | 75 | 86 | 4 | M39696 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COHESIN_LOADING | 1.29e-03 | 9 | 86 | 2 | M47868 | |
| Pathway | REACTOME_CA2_ACTIVATED_K_CHANNELS | 1.29e-03 | 9 | 86 | 2 | M26932 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 1.60e-03 | 10 | 86 | 2 | M27178 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 1.60e-03 | 10 | 86 | 2 | MM14892 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.60e-03 | 10 | 86 | 2 | M46430 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC24A5 TRPM6 SLC28A3 SLC2A2 SLC7A9 SLC7A8 SLC8A1 CLCNKA SLC26A7 SLC5A6 ATP6V0D2 SLC38A3 | 1.64e-03 | 736 | 86 | 12 | M27287 |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.71e-03 | 39 | 86 | 3 | MM15695 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 1.95e-03 | 11 | 86 | 2 | M27336 | |
| Pathway | REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION | 1.95e-03 | 11 | 86 | 2 | M27177 | |
| Pathway | REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION | 1.95e-03 | 11 | 86 | 2 | MM14891 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.98e-03 | 41 | 86 | 3 | M7399 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 2.33e-03 | 12 | 86 | 2 | MM15616 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 2.75e-03 | 13 | 86 | 2 | MM15078 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 2.75e-03 | 13 | 86 | 2 | MM15363 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 2.75e-03 | 13 | 86 | 2 | M27661 | |
| Pathway | WP_GPCRS_OTHER | 2.80e-03 | 96 | 86 | 4 | MM15939 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 3.13e-03 | 99 | 86 | 4 | M27474 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 3.19e-03 | 14 | 86 | 2 | M39328 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_NFKB_SIGNALING_PATHWAY | 3.67e-03 | 15 | 86 | 2 | M47816 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 3.67e-03 | 15 | 86 | 2 | MM15697 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 3.67e-03 | 15 | 86 | 2 | MM14536 | |
| Pubmed | OR8J3 OR5AK2 OR7A5 OR4Q2 OR13C3 OR4M1 OR4Q3 OR8J1 OR5M8 OR1D4 OR4K14 OR8B3 OR52E2 OR51L1 OR8A1 OR11H1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 OR4K5 OR8B2 OR4X1 OR4K15 OR2AG1 | 3.95e-25 | 541 | 107 | 27 | 14983052 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR8J3 OR5AK2 OR7A5 OR13C3 OR4M1 OR4Q3 OR5AK3P OR8J1 OR5M8 OR8B3 OR52E2 OR8A1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 OR4K5 OR8B2 OR4K15 OR2AG1 | 5.60e-23 | 340 | 107 | 22 | 11875048 |
| Pubmed | OR8J3 OR5AK2 OR7A5 OR13C3 OR4M1 OR4Q3 OR5AK3P OR8J1 OR5M8 OR8B3 OR52E2 OR8A1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 OR4K5 OR8B2 OR4K15 OR2AG1 | 5.60e-23 | 340 | 107 | 22 | 11802173 | |
| Pubmed | OR8J3 OR5AK2 OR7A5 OR13C3 OR4M1 OR4Q3 OR5AK3P OR8J1 OR5M8 OR8B3 OR52E2 OR8A1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 OR4K5 OR8B2 OR4K15 OR2AG1 | 6.79e-23 | 343 | 107 | 22 | 32295537 | |
| Pubmed | OR8J3 OR5AK2 OR7A5 OR13C3 OR4M1 OR4Q3 OR5AK3P OR8J1 OR5M8 OR8B3 OR52E2 OR8A1 OR4A15 OR52N4 OR1A1 OR1D5 OR5C1 OR56A3 OR4K5 OR8B2 OR4K15 OR2AG1 | 8.22e-23 | 346 | 107 | 22 | 14611657 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | OR8J3 OR7A5 OR4Q2 OR8J1 OR5M8 OR1D4 OR4K14 OR8A1 OR11H1 OR4A15 OR1A1 OR1D5 OR8B2 OR2AG1 | 7.36e-15 | 219 | 107 | 14 | 12213199 |
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 18203813 | ||
| Pubmed | Molecular cloning of the murine substance K and substance P receptor genes. | 2.83e-08 | 3 | 107 | 3 | 1370937 | |
| Pubmed | Expression of the tachykinin receptor mRNAs in healthy human colon. | 2.83e-08 | 3 | 107 | 3 | 18835556 | |
| Pubmed | Odorant and vomeronasal receptor genes in two mouse genome assemblies. | 1.15e-07 | 74 | 107 | 6 | 15081110 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 2.61e-07 | 139 | 107 | 7 | 16985003 | |
| Pubmed | Pharmacological profile of the novel mammalian tachykinin, hemokinin 1. | 2.82e-07 | 5 | 107 | 3 | 11786503 | |
| Pubmed | A role for tachykinins in female mouse and rat reproductive function. | 5.62e-07 | 6 | 107 | 3 | 12773411 | |
| Pubmed | Characterization of the endokinins: human tachykinins with cardiovascular activity. | 5.62e-07 | 6 | 107 | 3 | 12716968 | |
| Pubmed | A role for tachykinins in the regulation of human sperm motility. | 5.62e-07 | 6 | 107 | 3 | 17437961 | |
| Pubmed | 7.17e-07 | 23 | 107 | 4 | 10706615 | ||
| Pubmed | 9.82e-07 | 7 | 107 | 3 | 26074487 | ||
| Pubmed | 1.57e-06 | 8 | 107 | 3 | 32093886 | ||
| Pubmed | 1.57e-06 | 8 | 107 | 3 | 17448763 | ||
| Pubmed | 4.59e-06 | 11 | 107 | 3 | 20598684 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 31421907 | ||
| Pubmed | Integrin-mediated dendrite branch maintenance requires Abelson (Abl) family kinases. | 9.38e-06 | 2 | 107 | 2 | 15987940 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 16893949 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 32778134 | ||
| Pubmed | Role for NK(1) and NK(2) receptors in the motor activity in mouse colon. | 9.38e-06 | 2 | 107 | 2 | 17597603 | |
| Pubmed | PPARA: a novel genetic determinant of CYP3A4 in vitro and in vivo. | 9.38e-06 | 2 | 107 | 2 | 22510778 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 20715157 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 19158361 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 32067964 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 15611481 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 15647454 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 22665498 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 22715410 | ||
| Pubmed | Synthetic lethal interaction between the tumour suppressor STAG2 and its paralog STAG1. | 9.38e-06 | 2 | 107 | 2 | 28430577 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12220663 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 3313010 | ||
| Pubmed | Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes. | 9.38e-06 | 2 | 107 | 2 | 11279004 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 17686996 | ||
| Pubmed | Distinct functions of human cohesin-SA1 and cohesin-SA2 in double-strand break repair. | 9.38e-06 | 2 | 107 | 2 | 24324008 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 6302194 | ||
| Pubmed | ABL tyrosine kinases: evolution of function, regulation, and specificity. | 9.38e-06 | 2 | 107 | 2 | 20841568 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 11834499 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 11906947 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12427486 | ||
| Pubmed | Abl family tyrosine kinases regulate sialylated ganglioside receptors for polyomavirus. | 9.38e-06 | 2 | 107 | 2 | 20181697 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 34648034 | ||
| Pubmed | The primary structure and gene organization of human substance P and neuromedin K receptors. | 9.38e-06 | 2 | 107 | 2 | 1312928 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 35321830 | ||
| Pubmed | c-Abl and Arg tyrosine kinases regulate lysosomal degradation of the oncoprotein Galectin-3. | 9.38e-06 | 2 | 107 | 2 | 20150913 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 23142211 | ||
| Pubmed | Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer. | 9.38e-06 | 2 | 107 | 2 | 29649003 | |
| Pubmed | Global Regulation of Differential Gene Expression by c-Abl/Arg Oncogenic Kinases. | 9.38e-06 | 2 | 107 | 2 | 28555614 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 19805386 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 27341316 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 37958656 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 21892207 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 29350678 | ||
| Pubmed | Ca2+-dependent regulation of sodium channels NaV1.4 and NaV1.5 is controlled by the post-IQ motif. | 9.38e-06 | 2 | 107 | 2 | 30944319 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 28579309 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8120392 | ||
| Pubmed | Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts. | 9.38e-06 | 2 | 107 | 2 | 28691904 | |
| Pubmed | Dendritic mechanisms controlling the threshold and timing requirement of synaptic plasticity. | 9.38e-06 | 2 | 107 | 2 | 20087888 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 22415365 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 21679149 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 33122628 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 19822671 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 2163052 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 29502154 | ||
| Pubmed | STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers. | 9.38e-06 | 2 | 107 | 2 | 32467316 | |
| Pubmed | Specialized functions of cohesins STAG1 and STAG2 in 3D genome architecture. | 9.38e-06 | 2 | 107 | 2 | 32294612 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 31495782 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 26371842 | ||
| Pubmed | Abl family nonreceptor tyrosine kinases modulate short-term synaptic plasticity. | 9.38e-06 | 2 | 107 | 2 | 12626632 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 23295386 | ||
| Pubmed | The Abl family kinases: mechanisms of regulation and signaling. | 9.38e-06 | 2 | 107 | 2 | 12374288 | |
| Pubmed | Cis-acting regulatory elements regulating CYP3A4 transcription in human liver. | 9.38e-06 | 2 | 107 | 2 | 32301865 | |
| Pubmed | Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. | 9.38e-06 | 2 | 107 | 2 | 3021337 | |
| Pubmed | Defective T cell development and function in the absence of Abelson kinases. | 9.38e-06 | 2 | 107 | 2 | 18025176 | |
| Pubmed | Sequence, structure, and evolution of a complete human olfactory receptor gene cluster. | 1.54e-05 | 16 | 107 | 3 | 10673334 | |
| Pubmed | 1.54e-05 | 16 | 107 | 3 | 22154759 | ||
| Pubmed | The chromosomal distribution of mouse odorant receptor genes. | 2.38e-05 | 54 | 107 | 4 | 8570653 | |
| Pubmed | Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells. | 2.81e-05 | 3 | 107 | 2 | 15731117 | |
| Pubmed | MutS homologue hMSH5: role in cisplatin-induced DNA damage response. | 2.81e-05 | 3 | 107 | 2 | 22401567 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 23846873 | ||
| Pubmed | Two distinct phosphorylation pathways have additive effects on Abl family kinase activation. | 2.81e-05 | 3 | 107 | 2 | 12748290 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 32600668 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 12147261 | ||
| Pubmed | Abl family kinases regulate FcγR-mediated phagocytosis in murine macrophages. | 2.81e-05 | 3 | 107 | 2 | 23100514 | |
| Pubmed | Mouse liver cytochrome P-450 (P-450IIIAM1): its cDNA cloning and inducibility by dexamethasone. | 2.81e-05 | 3 | 107 | 2 | 1339292 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 22738912 | ||
| Pubmed | Predominantly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain. | 2.81e-05 | 3 | 107 | 2 | 12617959 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 9211900 | ||
| Pubmed | Ubiquitination and degradation of the Arg tyrosine kinase is regulated by oxidative stress. | 2.81e-05 | 3 | 107 | 2 | 15735735 | |
| Pubmed | Characterization of the interaction between the cohesin subunits Rad21 and SA1/2. | 2.81e-05 | 3 | 107 | 2 | 23874961 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 11726664 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 12569093 | ||
| Pubmed | PAR-2 agonists induce contraction of murine small intestine through neurokinin receptors. | 2.81e-05 | 3 | 107 | 2 | 12801882 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 29679912 | ||
| Pubmed | High fat diet induced obesity is mitigated in Cyp3a-null female mice. | 2.81e-05 | 3 | 107 | 2 | 29738703 | |
| Pubmed | A novel female-specific member of the CYP3A gene subfamily in the mouse liver. | 2.81e-05 | 3 | 107 | 2 | 10775455 | |
| Interaction | TAC1 interactions | 1.71e-07 | 12 | 89 | 4 | int:TAC1 | |
| Interaction | TAC4 interactions | 3.32e-07 | 4 | 89 | 3 | int:TAC4 | |
| Interaction | TSPAN15 interactions | 3.03e-05 | 276 | 89 | 8 | int:TSPAN15 | |
| Cytoband | 14q11.2 | 1.12e-08 | 180 | 107 | 8 | 14q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q11 | 1.20e-06 | 332 | 107 | 8 | chr14q11 | |
| Cytoband | 11q12.1 | 3.97e-05 | 161 | 107 | 5 | 11q12.1 | |
| Cytoband | 11p15.4 | 1.11e-04 | 200 | 107 | 5 | 11p15.4 | |
| Cytoband | 7q21.1 | 1.49e-04 | 8 | 107 | 2 | 7q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q24 | 1.07e-03 | 191 | 107 | 4 | chr11q24 | |
| Cytoband | 17p13.3 | 1.17e-03 | 88 | 107 | 3 | 17p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 1.32e-03 | 345 | 107 | 5 | chr11q12 | |
| Cytoband | 5p15.2 | 1.82e-03 | 27 | 107 | 2 | 5p15.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 2.13e-03 | 564 | 107 | 6 | chr11p15 | |
| Cytoband | 4q13.2 | 2.39e-03 | 31 | 107 | 2 | 4q13.2 | |
| GeneFamily | Tachykinin receptors | 1.15e-07 | 3 | 89 | 3 | 258 | |
| GeneFamily | Olfactory receptors, family 4 | 2.35e-07 | 129 | 89 | 8 | 151 | |
| GeneFamily | Solute carriers | SLC24A5 SLC46A2 SLC28A3 SLC2A2 SLC7A9 SLC7A8 SLC25A36 SLC8A1 SLC26A7 SLC5A6 SLC51A SLC38A3 | 5.22e-07 | 395 | 89 | 12 | 752 |
| GeneFamily | Olfactory receptors, family 8 | 4.15e-06 | 49 | 89 | 5 | 155 | |
| GeneFamily | Olfactory receptors, family 5 | 2.29e-04 | 112 | 89 | 5 | 152 | |
| GeneFamily | Potassium calcium-activated channels | 3.55e-04 | 6 | 89 | 2 | 255 | |
| GeneFamily | UDP glucuronosyltransferases | 5.16e-04 | 32 | 89 | 3 | 363 | |
| GeneFamily | Cytochrome P450 family 3 | 6.58e-04 | 8 | 89 | 2 | 1002 | |
| GeneFamily | Cohesin complex | 6.58e-04 | 8 | 89 | 2 | 1060 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 8.43e-04 | 9 | 89 | 2 | 1203 | |
| GeneFamily | Olfactory receptors, family 1 | 9.99e-04 | 40 | 89 | 3 | 147 | |
| GeneFamily | Dyneins, axonemal | 3.11e-03 | 17 | 89 | 2 | 536 | |
| GeneFamily | Olfactory receptors, family 11 | 5.67e-03 | 23 | 89 | 2 | 159 | |
| GeneFamily | SH2 domain containing | 1.36e-02 | 101 | 89 | 3 | 741 | |
| ToppCell | C_02|World / shred on cell type and cluster | 2.65e-06 | 165 | 105 | 6 | a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.96e-06 | 190 | 105 | 6 | 223587b5df037794a2cee234babf87d12bf48ac8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-06 | 193 | 105 | 6 | 46d5d1f8150ebbc7f1941b96ab184491e5c1210b | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.72e-06 | 194 | 105 | 6 | 12a2c60303607b8b5812405ad216d0612c56c64b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.72e-06 | 194 | 105 | 6 | a429d22c8c9d0fd3bfa9f877a6364cecad68db30 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.72e-06 | 194 | 105 | 6 | 15060cc25baf49dd04d9c20499e28718610ef754 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-06 | 195 | 105 | 6 | 3f517c6fc372bdcaf45b3af373414f13cbebd4ba | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Npy_(Cortical_subplate_interneuron)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.60e-05 | 64 | 105 | 4 | 28acc0d394b8cd2fd93ae5e0801f0ff1dd4b16ac | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Npy_(Cortical_subplate_interneuron)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.60e-05 | 64 | 105 | 4 | 61414e0fa2242f156f0f45f8733b831b7f965dd8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-05 | 137 | 105 | 5 | 81cdb216e6c81acf9c2072f9d39e1a42612e1258 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-05 | 145 | 105 | 5 | 9964d6d3769be2f35d86268fe044cecd1d5a1616 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.23e-05 | 154 | 105 | 5 | 511923b27469ea20f8bd82a9ec27119a6e884644 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-05 | 160 | 105 | 5 | 86fde32f096eaf9ea3677f57169cdcc0a57bb8dd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.77e-05 | 174 | 105 | 5 | 3d4c05ea5719ca65e85d1f15198453034791087c | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.26e-05 | 177 | 105 | 5 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Erythrophagocytic_macrophages|bone_marrow / Manually curated celltypes from each tissue | 6.77e-05 | 180 | 105 | 5 | daf69a548ed7c6f285a6adcff00f99aa22f9d6a5 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.91e-05 | 186 | 105 | 5 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.11e-05 | 187 | 105 | 5 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | 3'-Adult-Distal_Rectal-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.53e-05 | 189 | 105 | 5 | 0c612ff5f882f2d8ec744a347780bbbe7cc471bd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.53e-05 | 189 | 105 | 5 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.53e-05 | 189 | 105 | 5 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | 3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.53e-05 | 189 | 105 | 5 | bc8949bd4f425ed36e2c05e653c94cb1593c5bee | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.74e-05 | 190 | 105 | 5 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 8.74e-05 | 190 | 105 | 5 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.74e-05 | 190 | 105 | 5 | c408d4033a130c0168159a5b6f286fd2b2a9a39d | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.74e-05 | 190 | 105 | 5 | d4910c37045a8b8bb53b37625263bc0a47b6e3f8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.96e-05 | 191 | 105 | 5 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.96e-05 | 191 | 105 | 5 | adb2e3efcad02889d8229325080da5e7830fd3ae | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.96e-05 | 191 | 105 | 5 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.18e-05 | 192 | 105 | 5 | bacbaef1f230051335f4433e55db07a161b96b4c | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 9.18e-05 | 192 | 105 | 5 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.87e-05 | 195 | 105 | 5 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.87e-05 | 195 | 105 | 5 | 0ac7762197cdd8d643f87148573a8df6e936c1b0 | |
| ToppCell | (7)_MNP-(7)_Macrophage|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.01e-04 | 196 | 105 | 5 | 71ec157163278ad259c190051926bf41e4ecef46 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 196 | 105 | 5 | cd8c22c6f52f068a33525723108d6b5b23fe822d | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 196 | 105 | 5 | 6ee8dcc5cd643747e20d23b9556c17f7c102b19c | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-MoAM-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.06e-04 | 198 | 105 | 5 | 1d92b09aeb03a95fa9e221813002045c4f41dd24 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.06e-04 | 198 | 105 | 5 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 198 | 105 | 5 | 58508a8df2714d769f137794c29441a7bd38b350 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Transitional_AT2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.09e-04 | 199 | 105 | 5 | cd581d7330b471431ef427f8a4f5be553f70e068 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 199 | 105 | 5 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.11e-04 | 200 | 105 | 5 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.11e-04 | 200 | 105 | 5 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.11e-04 | 200 | 105 | 5 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.11e-04 | 200 | 105 | 5 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.11e-04 | 200 | 105 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.11e-04 | 200 | 105 | 5 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.11e-04 | 200 | 105 | 5 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| Computational | Genes in the cancer module 288. | 2.86e-05 | 37 | 52 | 4 | MODULE_288 | |
| Drug | ezlopitant | 8.99e-10 | 11 | 106 | 5 | CID000188927 | |
| Drug | (N-N'-bis-(2-(1H-indol-3-yl)-ethyl)-N,N'-bis-(3-thiomorpholin-4-yl-propyl)-phthalamide) | 9.81e-08 | 3 | 106 | 3 | ctd:C502587 | |
| Drug | NM-3 | 1.90e-07 | 54 | 106 | 6 | CID005493470 | |
| Drug | Men10354 | 3.91e-07 | 4 | 106 | 3 | CID003083370 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 5.78e-07 | 35 | 106 | 5 | CID010436171 | |
| Drug | Gr-94800 | 7.74e-07 | 16 | 106 | 4 | CID005487475 | |
| Drug | AC1L51LV | 9.74e-07 | 5 | 106 | 3 | CID000196380 | |
| Drug | 2-(4-nitrophenyl)benzoxazole | 9.74e-07 | 5 | 106 | 3 | CID000070047 | |
| Drug | L-703, 606 oxalate | 1.01e-06 | 17 | 106 | 4 | CID000003851 | |
| Drug | 2,2,2-trichloroethanol | 1.17e-06 | 73 | 106 | 6 | CID000008259 | |
| Drug | T4-G | 1.63e-06 | 19 | 106 | 4 | CID000152424 | |
| Drug | sodium | TRPM6 SLC28A3 GRIK1 SLC2A2 SLC7A9 SLC7A8 SLC8A1 CLCNKA SLC26A7 KCND2 SLC5A6 SCN4A SCN5A KCNMA1 KCNN3 TACR1 SLC38A3 | 1.66e-06 | 944 | 106 | 17 | CID000000923 |
| Drug | Spm-SP | 1.94e-06 | 6 | 106 | 3 | CID003081857 | |
| Drug | 5 alpha-androstane | 2.67e-06 | 84 | 106 | 6 | CID000094144 | |
| Drug | GR159897 | 3.39e-06 | 7 | 106 | 3 | CID003570748 | |
| Drug | Neurokinin A-oh | 3.39e-06 | 7 | 106 | 3 | CID000147040 | |
| Drug | LY303870 | 3.39e-06 | 7 | 106 | 3 | CID003086681 | |
| Drug | L-659,837 | 3.39e-06 | 7 | 106 | 3 | CID006444163 | |
| Drug | Men 10456 | 3.39e-06 | 7 | 106 | 3 | CID000189859 | |
| Drug | AC1O44I5 | 3.39e-06 | 7 | 106 | 3 | CID006324620 | |
| Drug | p-nitroanisole | 4.55e-06 | 92 | 106 | 6 | CID000007485 | |
| Drug | aniline | 4.61e-06 | 142 | 106 | 7 | CID000006115 | |
| Drug | oxazepam | 4.78e-06 | 53 | 106 | 5 | CID000004616 | |
| Drug | 2-naphthol | 4.85e-06 | 93 | 106 | 6 | CID000008663 | |
| Drug | Lom-TK-I | 5.40e-06 | 8 | 106 | 3 | CID000195503 | |
| Drug | Bhsar-SP | 5.40e-06 | 8 | 106 | 3 | CID000163829 | |
| Drug | AC1L4Z4R | 5.40e-06 | 8 | 106 | 3 | CID000194918 | |
| Drug | inaperisone | 8.07e-06 | 9 | 106 | 3 | CID000065860 | |
| Drug | Sp(7-11) | 8.07e-06 | 9 | 106 | 3 | CID003084967 | |
| Drug | phyllomedusin | 8.07e-06 | 9 | 106 | 3 | CID000168489 | |
| Drug | AC1MIXOF | 8.07e-06 | 9 | 106 | 3 | CID003081850 | |
| Drug | 4-hydroxybiphenyl | 8.15e-06 | 59 | 106 | 5 | CID000007103 | |
| Drug | 4-hydroxyestrone | 8.15e-06 | 59 | 106 | 5 | CID000018418 | |
| Drug | SN-38G | 8.15e-06 | 59 | 106 | 5 | CID000443154 | |
| Drug | Senktide | 8.34e-06 | 28 | 106 | 4 | CID000108147 | |
| Drug | L-idaro-1,4-lactone | 8.34e-06 | 28 | 106 | 4 | CID000078997 | |
| Drug | 7-hydroxycoumarin glucuronide | 9.64e-06 | 29 | 106 | 4 | CID000125641 | |
| Drug | methylglucamine | 1.04e-05 | 62 | 106 | 5 | CID000004049 | |
| Drug | Uperolein | 1.15e-05 | 10 | 106 | 3 | CID003085088 | |
| Drug | R396 | 1.15e-05 | 10 | 106 | 3 | CID000164286 | |
| Drug | AC1L2Y4S | 1.15e-05 | 10 | 106 | 3 | CID000130848 | |
| Drug | R 487 | 1.15e-05 | 10 | 106 | 3 | CID000131469 | |
| Drug | Nka-(4-10) | 1.58e-05 | 11 | 106 | 3 | CID000122230 | |
| Drug | Cp96 | 1.58e-05 | 11 | 106 | 3 | CID000086380 | |
| Drug | AC1Q5XN5 | 1.58e-05 | 11 | 106 | 3 | CID000190946 | |
| Drug | Mdl 28,564 | 1.58e-05 | 11 | 106 | 3 | CID003081745 | |
| Drug | BP-3,6-quinol | 1.64e-05 | 33 | 106 | 4 | CID000119292 | |
| Drug | lithocholic acid | 1.73e-05 | 116 | 106 | 6 | CID000009903 | |
| Drug | methoxyresorufin | 1.76e-05 | 69 | 106 | 5 | CID000119220 | |
| Drug | AC1Q7AUJ | 1.82e-05 | 117 | 106 | 6 | CID000003303 | |
| Drug | fibrates | 1.91e-05 | 118 | 106 | 6 | CID000002797 | |
| Drug | alpha-naphthoflavone | 1.91e-05 | 118 | 106 | 6 | CID000011790 | |
| Drug | benzphetamine | 2.00e-05 | 119 | 106 | 6 | CID000002341 | |
| Drug | AC1NOWCJ | 2.08e-05 | 35 | 106 | 4 | CID005120112 | |
| Drug | Mdl 29913 | 2.09e-05 | 12 | 106 | 3 | CID003081272 | |
| Drug | Flecainide | 2.15e-05 | 2 | 106 | 2 | DB01195 | |
| Drug | senktide | 2.15e-05 | 2 | 106 | 2 | ctd:C054724 | |
| Drug | GR 159897 | 2.15e-05 | 2 | 106 | 2 | ctd:C092990 | |
| Drug | 2-hydroxyestriol | 2.15e-05 | 2 | 106 | 2 | ctd:C008012 | |
| Drug | eugenol | 2.32e-05 | 73 | 106 | 5 | CID000003314 | |
| Drug | l-borneol | 2.60e-05 | 37 | 106 | 4 | CID000010049 | |
| Drug | 7-hydroxycoumarin | 2.65e-05 | 75 | 106 | 5 | CID005281426 | |
| Drug | Scyliorhinin I | 2.71e-05 | 13 | 106 | 3 | CID000147048 | |
| Drug | PD140548 | 2.71e-05 | 13 | 106 | 3 | CID005311347 | |
| Drug | pranlukast | 2.83e-05 | 76 | 106 | 5 | CID000004887 | |
| Drug | hexobarbital | 2.89e-05 | 127 | 106 | 6 | CID000003608 | |
| Drug | tetradotoxin | GRIK1 P2RY1 KCND2 SCN4A SCN5A KCNMA1 KCNN3 TACR2 TACR1 TACR3 | 3.17e-05 | 428 | 106 | 10 | CID000020382 |
| Drug | benzyloxyresorufin | 3.21e-05 | 78 | 106 | 5 | CID000114982 | |
| Drug | AC1N8H7N | 3.21e-05 | 78 | 106 | 5 | CID004318740 | |
| Drug | Gr 73632 | 3.44e-05 | 14 | 106 | 3 | CID000119599 | |
| Drug | harmol | 3.56e-05 | 40 | 106 | 4 | CID000068094 | |
| Drug | emend | 3.56e-05 | 40 | 106 | 4 | CID000151165 | |
| Drug | acridine | 3.85e-05 | 81 | 106 | 5 | CID000009215 | |
| Drug | 2-AF | 3.94e-05 | 41 | 106 | 4 | CID000005800 | |
| Drug | androsterone glucuronide | 4.76e-05 | 43 | 106 | 4 | CID000114833 | |
| Drug | 7,8-benzoquinoline | 4.76e-05 | 43 | 106 | 4 | CID000009191 | |
| Drug | 7-ethoxycoumarin | 5.13e-05 | 86 | 106 | 5 | CID000035703 | |
| Drug | MS-222 | 5.22e-05 | 44 | 106 | 4 | CID000011400 | |
| Drug | Men 10627 | 5.26e-05 | 16 | 106 | 3 | CID006438356 | |
| Drug | Fk 224 | 5.26e-05 | 16 | 106 | 3 | CID006437864 | |
| Drug | menthol | 5.43e-05 | 87 | 106 | 5 | CID000001254 | |
| Drug | pentoxyresorufin | 5.43e-05 | 87 | 106 | 5 | CID000107683 | |
| Drug | butylated hydroxytoluene | 5.63e-05 | 143 | 106 | 6 | CID000031404 | |
| Drug | mangiferin | 5.63e-05 | 143 | 106 | 6 | ctd:C013592 | |
| Drug | 2 E1 | 6.08e-05 | 145 | 106 | 6 | CID006102788 | |
| Drug | naringin | 6.32e-05 | 146 | 106 | 6 | ctd:C005274 | |
| Drug | alaninamide | 6.36e-05 | 17 | 106 | 3 | CID000350287 | |
| Drug | tetrapentylammonium | 6.36e-05 | 17 | 106 | 3 | CID000017248 | |
| Drug | MEN 11420 | 6.36e-05 | 17 | 106 | 3 | CID003086682 | |
| Drug | L-732,138 | 6.36e-05 | 17 | 106 | 3 | CID000132837 | |
| Drug | salicylamide | 7.38e-05 | 48 | 106 | 4 | CID000005147 | |
| Drug | Dimethyl C7 | 7.61e-05 | 18 | 106 | 3 | CID000123994 | |
| Drug | moricizine | 7.61e-05 | 18 | 106 | 3 | CID000034632 | |
| Drug | C1 11-32 | 7.61e-05 | 18 | 106 | 3 | CID000443077 | |
| Drug | C11131 | 7.61e-05 | 18 | 106 | 3 | CID000443076 | |
| Drug | V ms | 8.00e-05 | 49 | 106 | 4 | CID005289556 | |
| Drug | ethoxyresorufin | 8.26e-05 | 95 | 106 | 5 | CID000003294 | |
| Drug | DCNB | 8.26e-05 | 95 | 106 | 5 | CID000007443 | |
| Drug | GR 64349 | 9.00e-05 | 19 | 106 | 3 | CID003036081 | |
| Drug | DB04103 | 9.12e-05 | 97 | 106 | 5 | CID004469987 | |
| Disease | X-24947 measurement | 6.48e-07 | 22 | 93 | 4 | EFO_0800910 | |
| Disease | methionine sulfone measurement | 6.53e-06 | 12 | 93 | 3 | EFO_0800072 | |
| Disease | Bronchial Diseases | 2.94e-05 | 3 | 93 | 2 | C0006261 | |
| Disease | Torsades de Pointes | 2.94e-05 | 3 | 93 | 2 | C0040479 | |
| Disease | unipolar depression, smoking behaviour measurement | 5.87e-05 | 4 | 93 | 2 | EFO_0003761, EFO_0005671 | |
| Disease | epiandrosterone sulfate measurement | 6.63e-05 | 25 | 93 | 3 | EFO_0021120 | |
| Disease | emphysema imaging measurement | 1.01e-04 | 146 | 93 | 5 | EFO_0007626 | |
| Disease | Failure to Thrive | 1.46e-04 | 6 | 93 | 2 | C0015544 | |
| Disease | Vomiting | 2.04e-04 | 7 | 93 | 2 | C0042963 | |
| Disease | vitamin D deficiency | 2.18e-04 | 37 | 93 | 3 | EFO_0003762 | |
| Disease | colitis (biomarker_via_orthology) | 3.18e-04 | 42 | 93 | 3 | DOID:0060180 (biomarker_via_orthology) | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 3.49e-04 | 9 | 93 | 2 | EFO_0600040 | |
| Disease | glycogen storage disease (is_implicated_in) | 3.49e-04 | 9 | 93 | 2 | DOID:2747 (is_implicated_in) | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 4.35e-04 | 10 | 93 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 4.35e-04 | 10 | 93 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 4.35e-04 | 10 | 93 | 2 | EFO_0800289 | |
| Disease | Schizophrenia | IL10 CYP3A4 AVPR1A GRIK1 PPARA CNPPD1 SLC26A7 KCNN3 TACR3 PLXNA2 | 4.70e-04 | 883 | 93 | 10 | C0036341 |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 5.31e-04 | 11 | 93 | 2 | EFO_0800295 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 6.35e-04 | 12 | 93 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 6.35e-04 | 12 | 93 | 2 | EFO_0800291 | |
| Disease | testosterone measurement | TRPM6 STAG1 CYP3A4 MFSD9 SLC28A3 PPARA ARL15 C3P1 UGT2B7 TACR3 SLC51A UGT2B11 | 6.62e-04 | 1275 | 93 | 12 | EFO_0004908 |
| Disease | pipecolate measurement | 7.49e-04 | 13 | 93 | 2 | EFO_0021006 | |
| Disease | X-19141 measurement | 7.49e-04 | 13 | 93 | 2 | EFO_0800799 | |
| Disease | serum metabolite measurement | CYP3A4 CYP3A43 PIK3R3 SLC28A3 KBTBD2 REV3L SLC7A9 SLC5A6 OR1D5 SLC51A | 7.93e-04 | 945 | 93 | 10 | EFO_0005653 |
| Disease | Global developmental delay | 8.45e-04 | 133 | 93 | 4 | C0557874 | |
| Disease | X-21470 measurement | 8.72e-04 | 14 | 93 | 2 | EFO_0800817 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 8.72e-04 | 14 | 93 | 2 | EFO_0800283 | |
| Disease | Osteopenia | 1.00e-03 | 15 | 93 | 2 | C0029453 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 1.00e-03 | 15 | 93 | 2 | EFO_0800301 | |
| Disease | 5-oxoproline measurement | 1.15e-03 | 16 | 93 | 2 | EFO_0010988 | |
| Disease | X-21410 measurement | 1.15e-03 | 16 | 93 | 2 | EFO_0800813 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 1.15e-03 | 16 | 93 | 2 | EFO_0800305 | |
| Disease | free androgen index | 1.20e-03 | 374 | 93 | 6 | EFO_0007005 | |
| Disease | amino acid measurement | 1.37e-03 | 678 | 93 | 8 | EFO_0005134 | |
| Disease | phosphatidylcholine 36:4 measurement | 1.45e-03 | 18 | 93 | 2 | EFO_0010382 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 1.45e-03 | 18 | 93 | 2 | EFO_0800288 | |
| Disease | metabolonic lactone sulfate measurement | 1.62e-03 | 19 | 93 | 2 | EFO_0800659 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 1.78e-03 | 274 | 93 | 5 | EFO_0004530, EFO_0004612 | |
| Disease | metabolite measurement | 1.98e-03 | 560 | 93 | 7 | EFO_0004725 | |
| Disease | chronic myeloid leukemia (is_implicated_in) | 1.98e-03 | 21 | 93 | 2 | DOID:8552 (is_implicated_in) | |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 2.18e-03 | 22 | 93 | 2 | EFO_0021115 | |
| Disease | Intellectual Disability | 2.94e-03 | 447 | 93 | 6 | C3714756 | |
| Disease | inflammatory biomarker measurement | 3.04e-03 | 26 | 93 | 2 | EFO_0004872 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SMYVLSELVETEKMY | 161 | Q86VW2 | |
| MSDLRITEAFLYMDY | 1 | Q9NXU5 | |
| FLTGEFIYRMYTIDM | 391 | Q86XM0 | |
| MLMYDIVHYSESGVI | 216 | Q96LI9 | |
| LLYMATQISSAMEYL | 386 | P42684 | |
| AALMYDAVYMVAIAS | 321 | P39086 | |
| FTTMALLTIMEFSVY | 41 | Q96RQ1 | |
| VLYVASSLFLMVMYF | 666 | Q6ZRP7 | |
| VITYIACLMQMYFFI | 91 | Q15622 | |
| LLMLVTSDMYTLINY | 376 | Q9UHI5 | |
| LMESAVLVAMAYDSY | 111 | Q8NGJ4 | |
| LRSYFIYSMCTTVAM | 211 | P47900 | |
| MYYFLAMLSFTDLVM | 61 | Q8NGI2 | |
| ECVYLLMVTMSTVGY | 341 | Q12791 | |
| IFRYSFYMLTCIDMD | 256 | Q9P035 | |
| FDIFINYIEAYMTMK | 161 | P22301 | |
| AMAVMLYYSNFVLAL | 296 | Q8NBP5 | |
| SILTQEIMVYLAMYM | 891 | P46020 | |
| ITMAYIDYNMIVAFM | 51 | Q53G44 | |
| TYDTVLQMEYLDMVV | 346 | P08684 | |
| AALSVYAAMYLTMYI | 196 | Q32ZL2 | |
| MAFSIDQRYLYVMSE | 486 | O75051 | |
| IAMTYERILYISLEM | 356 | Q9UGI6 | |
| ILLVVMAYDRYMAIC | 141 | Q8NGL6 | |
| TEVAILTVMSYDRYM | 111 | Q8NHC6 | |
| MYYFISILAVNDLGM | 61 | Q8NGJ5 | |
| EMVLLVSMAYDRYVA | 111 | Q8NGD3 | |
| AEMVLLVSMAYDRYV | 111 | Q8NGD5 | |
| EMVLLVSMAYDRYVA | 111 | Q8NH41 | |
| EMFLLTVMAYDRYAA | 111 | Q8NGD0 | |
| AEMFLLTVMAYDRYV | 111 | P0C623 | |
| SEMFLLTVMAYDRYV | 111 | Q8NH05 | |
| FLLMVMAYDRYVAIC | 111 | Q8NH49 | |
| LYFLITEMSMVNIMY | 3691 | Q96JB1 | |
| MSYVSMIAIFLFVSF | 396 | P11168 | |
| VVHDCIYVMTLNLMY | 426 | Q8IY47 | |
| LTMAIIIFATVMFYA | 331 | Q9NZV8 | |
| DTSRYELMVYVMGVT | 191 | Q9H205 | |
| AVAMMYGTLIFMYLR | 251 | Q8NGR4 | |
| FFVISECYMLTSMAY | 106 | Q8NGG8 | |
| IAVTVFYGTMLFMYL | 246 | Q8NGG0 | |
| TQRMMLYDTSILYCY | 246 | Q13868 | |
| VIALLIYMMATTYNY | 236 | Q13491 | |
| MRLIVSYVYKSLMTF | 1386 | Q8IVE3 | |
| DMSVYYMIVCLIAFT | 146 | P55082 | |
| FSYIYIMVTILKMSS | 216 | Q8NH89 | |
| TTECFLLVMMAYDRY | 111 | Q9NZP5 | |
| SFYAVCFYLLMLVMV | 121 | Q86UW1 | |
| FSYIYIMATILKMSS | 216 | Q8NH90 | |
| YLAELMIYVSMAVTF | 256 | Q9H8P0 | |
| FFIVSEVIMLALMAY | 106 | Q8NGP2 | |
| EVIMLALMAYDRYVA | 111 | Q8NGP2 | |
| MAVTIFYGTLLFMYV | 246 | Q8NGP2 | |
| REVMMPYSTELIFYI | 16 | Q92569 | |
| DLFLISMMVASKYLY | 121 | Q9BV87 | |
| EAMAYFAMVKRYLTS | 546 | P07199 | |
| TYDALVQMEYLDMVV | 346 | Q9HB55 | |
| TSYVFRVFALAYSMM | 196 | Q6ZMU1 | |
| CYILMNVSYFTVMTA | 266 | P82251 | |
| IVMVFMSLYSVLYMS | 431 | Q92819 | |
| LYMATQISSAMEYLE | 341 | P00519 | |
| MMTDLLTEYAKTFGY | 1356 | Q9Y4F3 | |
| IYSMTAIAADRYMAI | 121 | P21452 | |
| LYFLITEMRLVNEMY | 3826 | Q8TE73 | |
| IAECYMLTVMAYDRY | 126 | Q8NGG7 | |
| AVVSLCYSSLMVMYV | 261 | Q8NG94 | |
| AVVSLCYSSLMVMYV | 261 | B2RN74 | |
| LMVIFFSYMFILYTI | 241 | Q8NGS6 | |
| FFVISECYMLTSMAY | 106 | Q96RD0 | |
| YGVYEAIFAMLSSVM | 311 | Q07869 | |
| MYFMIALGNTDSYIL | 101 | Q9P1Q5 | |
| YSMKDSVATVMYAVL | 266 | P47884 | |
| YSMKDSVATVMYAVL | 266 | P58170 | |
| ISNLSIAVMYIMYFL | 321 | Q99624 | |
| LDFSVIMMAYLTEFV | 196 | P35499 | |
| MSTFSIMDYVVFVLL | 21 | Q9Y289 | |
| YSMTAVAFDRYMAII | 121 | P25103 | |
| MRAVLEYLYTGMFTS | 551 | Q9BYZ6 | |
| YADKMFTYVFVLEML | 1241 | Q14524 | |
| TSLMTIMEDYFAYRG | 1106 | P51532 | |
| RIFIIMYGVTSMYFS | 386 | P46977 | |
| AIMMATYELVVYLLN | 296 | Q96CQ1 | |
| IAITMMKVYENYSFE | 2371 | O75592 | |
| MTYMIVCKLLSEIYE | 591 | O15457 | |
| SCTFMVMAYDRYVAI | 116 | Q8NH54 | |
| IYILAVMAFDRYMAI | 111 | Q8NGP6 | |
| AMYVAIQAMLSLYTS | 831 | P0CG38 | |
| IVVFFSTVMSMLYYL | 291 | Q9HAS3 | |
| ASIYSMTAIAVDRYM | 171 | P29371 | |
| YFLMTLGVLMALVSY | 51 | P51800 | |
| RALIMSTYYVAQMLV | 206 | Q8N2M4 | |
| TMAYLAFLMLFTYTV | 846 | Q9BX84 | |
| MFSVRIVTADYYMAS | 1 | O60673 | |
| IYDEYMMDTVISLLT | 191 | Q8N3U4 | |
| RTVYVYLEKFMTFQM | 1016 | Q8N3U4 | |
| MVYFAVIMQDYERVV | 556 | Q9P253 | |
| FYAMYNTLVARSEMV | 1911 | Q9H5I5 | |
| IYFLIIVYMFMAISI | 71 | Q71RS6 | |
| IVYMFMAISIVCDEY | 76 | Q71RS6 | |
| YSIIYDEYMMDTVIS | 191 | Q8WVM7 | |
| TFMERVKNMIYVLYF | 206 | O75310 | |
| FASAYMLVVMTADRY | 136 | P37288 | |
| TIFVLKILVMFYYLM | 306 | Q9H0C1 | |
| ASTILYFGYTMIMVL | 621 | Q99805 | |
| TYMFYIARAVMLFAL | 371 | Q9BY10 | |
| TFMERVKNMIYVLYF | 206 | Q9BY64 | |
| TFMERVKNMIYVLYF | 206 | P16662 | |
| FFDYSGVSMLVEVYM | 581 | Q8TE54 | |
| MKEVLVSSMLSAYYV | 286 | Q9GZU3 | |
| FLTYMTCSYMIDNVI | 96 | Q8N8Y2 | |
| ARATVYFVAMVYMFL | 76 | P32418 | |
| MLDRYEYQMSISIVM | 531 | Q92802 |